Immunotherapies have revolutionized the treatment paradigms of various types of cancers.
However, most of these immunomodulatory strategies focus on harnessing adaptive …

Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer
compounds that are widely used in the treatment of hematologic malignancies and solid …

Currently, certain cancer patients exhibit resistance to radiotherapy due to reduced DNA
damage under hypoxic conditions and acquired immune tolerance triggered by transforming …

Cancer cells alter mechanical tension in their cell membranes. New interventions to regulate
cell membrane tension present a potential strategy for cancer therapy. Herein, the increase …

Non-targeted effects (NTE) have been generally regarded as a low-dose ionizing radiation
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …

Therapy‐induced immunogenic cell death (ICD) can initiate both innate and adaptive
immune responses for amplified anti‐tumor efficacy. However, dying cell‐released ICD …

Nowadays, effective immunotherapy against triple-negative breast cancer (TNBC) remains
challenging due to the immunosuppressive tumor microenvironment. Immune checkpoint …

Chemotherapy is a cornerstone of cancer treatment, but it can also induce immune
suppression, which can have significant implications for patient outcomes. This review paper …

Fatty acid metabolism, particularly fatty acid synthesis, is a very important cellular
physiological process in which nutrients are used for energy storage and biofilm synthesis …

The human dendritic cell (DC) family has recently been expanded by CD1c+ CD14+
CD163+ DCs, introduced as DC3s. DC3s are found in tumors and peripheral blood of …